{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:20:30Z","timestamp":1790662830633,"version":"4.1.0"},"reference-count":106,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T00:00:00Z","timestamp":1753833600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jhltopen.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHLT Open"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jhlto.2025.100362","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T22:28:14Z","timestamp":1754432894000},"page":"100362","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Respiratory viral infections in lung transplantation: Recent advances in epidemiology, clinical impact, and therapeutic approaches"],"prefix":"10.1016","volume":"10","author":[{"given":"Hannah","family":"Bahakel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5691-5221","authenticated-orcid":false,"given":"Lara","family":"Danziger-Isakov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.jhlto.2025.100362_bib1","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.ajt.2024.03.011","article-title":"Longitudinal outcomes of COVID-19 in solid organ transplant recipients from 2020 to 2023","volume":"24","author":"Solera","year":"2024","journal-title":"Am J Transplant"},{"issue":"8","key":"10.1016\/j.jhlto.2025.100362_bib2","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1111\/ajt.16692","article-title":"COVID-19 in hospitalized lung and non-lung solid organ transplant recipients: a comparative analysis from a multicenter study","volume":"21","author":"Heldman","year":"2021","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1016\/j.jhlto.2025.100362_bib3","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.healun.2018.09.020","article-title":"Validation of a post-transplant chronic lung allograft dysfunction classification system","volume":"38","author":"Van Herck","year":"2019","journal-title":"J Heart Lung Transplant"},{"issue":"4","key":"10.1016\/j.jhlto.2025.100362_bib4","article-title":"Clinical progression, disease severity, and mortality among adults hospitalized with COVID-19 caused by the Omicron and Delta SARS-CoV-2 variants: a population-based, matched cohort study","volume":"18","author":"Group C-ODS","year":"2023","journal-title":"PLoS One"},{"issue":"10332","key":"10.1016\/j.jhlto.2025.100362_bib5","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S0140-6736(22)00462-7","article-title":"Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B. 1.1. 529) and delta (B. 1.617. 2) variants in England: a cohort study","volume":"399","author":"Nyberg","year":"2022","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.jhlto.2025.100362_bib6","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.healun.2022.06.011","article-title":"The effect of COVID-19 on transplant function and development of CLAD in lung transplant patients: a multicenter experience","volume":"41","author":"Roosma","year":"2022","journal-title":"J Heart Lung Transplant"},{"issue":"11","key":"10.1016\/j.jhlto.2025.100362_bib7","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.humimm.2022.07.007","article-title":"Association between SARS-CoV-2 infection and de novo HLA donor specific antibody production in lung transplant recipients: single-center study","volume":"83","author":"Shah","year":"2022","journal-title":"Hum Immunol"},{"key":"10.1016\/j.jhlto.2025.100362_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.trim.2024.102161","article-title":"Severe SARS-CoV-2 infection is associated with increased risk of De novo HLA antibody production in lung transplant recipients: Single-center study","volume":"88","author":"Shah","year":"2025","journal-title":"Transplant Immunol"},{"issue":"6","key":"10.1016\/j.jhlto.2025.100362_bib9","doi-asserted-by":"crossref","DOI":"10.1097\/TXD.0000000000001485","article-title":"Pre-exposure Prophylaxis with Tixagevimab-cilgavimab did not Reduce Severity of COVID-19 in Lung Transplant Recipients with Breakthrough Infection","volume":"9","author":"Sindu","year":"2023","journal-title":"Transplant Direct"},{"issue":"4","key":"10.1016\/j.jhlto.2025.100362_bib10","doi-asserted-by":"crossref","DOI":"10.1111\/tid.14086","article-title":"A single-center review of pre-exposure prophylaxis with tixagevimab\u2013cilgavimab in solid organ transplant recipients","volume":"25","author":"Morado","year":"2023","journal-title":"Transplant Infect Dis"},{"key":"10.1016\/j.jhlto.2025.100362_bib11","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciae435","article-title":"2024 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Management of COVID-19: Anti-SARS-CoV-2 Neutralizing Antibody Pemivibart for Pre-exposure Prophylaxis","author":"Bhimraj","year":"2024","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.jhlto.2025.100362_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-2600(21)00184-3","article-title":"Early humoral response among lung transplant recipients vaccinated with BNT162b2 vaccine","volume":"9","author":"Shostak","year":"2021","journal-title":"Lancet Respir Med"},{"issue":"7","key":"10.1016\/j.jhlto.2025.100362_bib13","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.3390\/vaccines10071130","article-title":"Immune response after mRNA COVID-19 vaccination in lung transplant recipients: A 6-month follow-up","volume":"10","author":"Tobudic","year":"2022","journal-title":"Vaccines"},{"key":"10.1016\/j.jhlto.2025.100362_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2025.126851","article-title":"SARS-CoV-2 spike antibody levels in lung transplantation recipients versus the spectrum in non-immunocompromised persons","volume":"50","author":"Shino","year":"2025","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.jhlto.2025.100362_bib15","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.cmi.2022.12.004","article-title":"Immunogenicity of COVID-19 vaccines in solid organ transplant recipients: a systematic review and meta-analysis","volume":"29","author":"Chen","year":"2023","journal-title":"Clin Microbiol Infect"},{"issue":"10","key":"10.1016\/j.jhlto.2025.100362_bib16","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.3390\/vaccines10101642","article-title":"Evaluation of immunogenicity to three doses of the SARS-CoV-2 BNT162b2 mRNA vaccine in lung transplant patients","volume":"10","author":"Guardiani","year":"2022","journal-title":"Vaccines"},{"issue":"2","key":"10.1016\/j.jhlto.2025.100362_bib17","doi-asserted-by":"crossref","first-page":"226","DOI":"10.7326\/M21-3480","article-title":"Neutralization of SARS-CoV-2 variants in transplant recipients after two and three doses of mRNA-1273 vaccine: secondary analysis of a randomized trial","volume":"175","author":"Kumar","year":"2022","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.jhlto.2025.100362_bib18","doi-asserted-by":"crossref","first-page":"4489","DOI":"10.1038\/s41467-022-32235-x","article-title":"Homotypic and heterotypic immune responses to Omicron variant in immunocompromised patients in diverse clinical settings","volume":"13","author":"Ferreira","year":"2022","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.jhlto.2025.100362_bib19","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13705","article-title":"Clinical effectiveness of COVID-19 vaccination in solid organ transplant recipients","volume":"23","author":"Aslam","year":"2021","journal-title":"Transplant Infect Dis"},{"issue":"9","key":"10.1016\/j.jhlto.2025.100362_bib20","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.healun.2021.05.003","article-title":"Clinical characteristics, management practices, and outcomes among lung transplant patients with COVID-19","volume":"40","author":"Mohanka","year":"2021","journal-title":"J Heart Lung Transplant"},{"issue":"4","key":"10.1016\/j.jhlto.2025.100362_bib21","doi-asserted-by":"crossref","first-page":"S751","DOI":"10.1016\/j.healun.2025.02.1621","article-title":"Remdesivir treatment and long-term outcomes in lung transplant recipients with COVID-19: a retrospective cohort study","volume":"44","author":"Vulturar","year":"2025","journal-title":"J Heart Lung Transplant"},{"issue":"1","key":"10.1016\/j.jhlto.2025.100362_bib22","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/ajt.17199","article-title":"Short-course early outpatient remdesivir prevents severe disease due to COVID-19 in organ transplant recipients during the omicron BA. 2 wave","volume":"23","author":"Solera","year":"2023","journal-title":"Am J Transplant"},{"issue":"4","key":"10.1016\/j.jhlto.2025.100362_bib23","doi-asserted-by":"crossref","first-page":"S165","DOI":"10.1016\/j.healun.2023.02.1653","article-title":"349) Molnupiravir vs Remdesivir for Treatment of Covid-19 in Lung Transplant Recipients","volume":"42","author":"Razia","year":"2023","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.jhlto.2025.100362_bib24","unstructured":"Ging P., Ison, Michael, Patel, Jignesh, Vidal Campos, Silvia, Vos, Robin, Aslam, Saima. New ISHLT COVID-19 Therapeutics Guidance: International Society of Heart and Lung Transplantation; 2023 [Available from: \u3008https:\/\/www.ishlt.org\/docs\/default-source\/default-document-library\/2023\u201304-04-ishlt-covid-guidance.pdf?sfvrsn=98ebd832_1\u3009."},{"issue":"3","key":"10.1016\/j.jhlto.2025.100362_bib25","doi-asserted-by":"crossref","first-page":"e342","DOI":"10.1093\/cid\/ciac443","article-title":"Effectiveness of paxlovid in reducing severe coronavirus disease 2019 and mortality in high-risk patients","volume":"76","author":"Najjar-Debbiny","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"15","key":"10.1016\/j.jhlto.2025.100362_bib26","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1056\/NEJMc2120219","article-title":"Resistance mutations in SARS-CoV-2 Delta variant after sotrovimab use","volume":"386","author":"Rockett","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhlto.2025.100362_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.100991","article-title":"Analysis of SARS-CoV-2 mutations associated with resistance to therapeutic monoclonal antibodies that emerge after treatment","volume":"71","author":"Focosi","year":"2023","journal-title":"Drug Resist Updates"},{"issue":"8","key":"10.1016\/j.jhlto.2025.100362_bib28","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Group RC. Dexamethasone in hospitalized patients with Covid-19","volume":"384","year":"2021","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jhlto.2025.100362_bib29","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13556","article-title":"A retrospective matched cohort single-center study evaluating outcomes of COVID-19 and the impact of immunomodulation on COVID-19-related cytokine release syndrome in solid organ transplant recipients","volume":"23","author":"Ringer","year":"2021","journal-title":"Transplant Infect Dis"},{"issue":"2","key":"10.1016\/j.jhlto.2025.100362_bib30","doi-asserted-by":"crossref","DOI":"10.1111\/tid.14050","article-title":"Immunomodulators for severe coronavirus disease-2019 in transplant patients: Do they increase the risk of secondary infection?","volume":"25","author":"Mendoza","year":"2023","journal-title":"Transplant Infect Dis"},{"key":"10.1016\/j.jhlto.2025.100362_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12985-021-01700-2","article-title":"Evaluation of the therapeutic regimen in COVID-19 in transplant patients: where do immunomodulatory and antivirals stand?","volume":"18","author":"Shafiekhani","year":"2021","journal-title":"Virol J"},{"issue":"5","key":"10.1016\/j.jhlto.2025.100362_bib32","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1111\/ajt.16364","article-title":"COVID-19 in lung transplant recipients: A multicenter study","volume":"21","author":"Saez-Gim\u00e9nez","year":"2021","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1016\/j.jhlto.2025.100362_bib33","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-68013-6","article-title":"Clinical outcomes of immunomodulation therapy in immunocompromised patients with severe Covid-19 and high oxygen requirement","volume":"14","author":"Goldstein","year":"2024","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.jhlto.2025.100362_bib34","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1111\/ajt.16383","article-title":"Burden, epidemiology, and outcomes of microbiologically confirmed respiratory viral infections in solid organ transplant recipients: a nationwide, multi-season prospective cohort study","volume":"21","author":"Mombelli","year":"2021","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1016\/j.jhlto.2025.100362_bib35","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.diagmicrobio.2016.02.025","article-title":"Morbidity and mortality among patients with respiratory syncytial virus infection: a 2-year retrospective review","volume":"85","author":"Anderson","year":"2016","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"4","key":"10.1016\/j.jhlto.2025.100362_bib36","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.ccm.2017.07.012","article-title":"Respiratory viral infections in solid organ and hematopoietic stem cell transplantation","volume":"38","author":"Paulsen","year":"2017","journal-title":"Clinics in chest medicine"},{"issue":"5","key":"10.1016\/j.jhlto.2025.100362_bib37","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1111\/ajt.14042","article-title":"Epidemiology and immediate indirect effects of respiratory viruses in lung transplant recipients: a 5-year prospective study","volume":"17","author":"Peghin","year":"2017","journal-title":"Am J Transplant"},{"issue":"6","key":"10.1016\/j.jhlto.2025.100362_bib38","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.cmi.2020.07.050","article-title":"Incidence, management and outcome of respiratory syncytial virus infection in adult lung transplant recipients: a 9-year retrospective multicentre study","volume":"27","author":"Testaert","year":"2021","journal-title":"Clin Microbiol Infect"},{"issue":"12","key":"10.1016\/j.jhlto.2025.100362_bib39","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1093\/cid\/ciab969","article-title":"Respiratory syncytial virus, human metapneumovirus, and parainfluenza virus infections in lung transplant recipients: a systematic review of outcomes and treatment strategies","volume":"74","author":"De Zwart","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.jhlto.2025.100362_bib40","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13511","article-title":"Practice ASoTIDCo. RNA respiratory viral infections in solid organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice","volume":"33","author":"Manuel","year":"2019","journal-title":"Clinical Transplant"},{"issue":"16","key":"10.1016\/j.jhlto.2025.100362_bib41","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2216480","article-title":"Bivalent prefusion F vaccine in pregnancy to prevent RSV illness in infants","volume":"388","author":"Kampmann","year":"2023","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.jhlto.2025.100362_bib42","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1056\/NEJMoa2209604","article-title":"Respiratory syncytial virus prefusion F protein vaccine in older adults","volume":"388","author":"Papi","year":"2023","journal-title":"N Engl J Med"},{"issue":"16","key":"10.1016\/j.jhlto.2025.100362_bib43","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1056\/NEJMoa2213836","article-title":"Efficacy and safety of a bivalent RSV prefusion F vaccine in older adults","volume":"388","author":"Walsh","year":"2023","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.jhlto.2025.100362_bib44","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.ajt.2024.02.003","article-title":"The respiratory syncytial virus vaccines are here: Implications for solid organ transplantation","volume":"24","author":"Trubin","year":"2024","journal-title":"Am J Transplant"},{"issue":"24","key":"10.1016\/j.jhlto.2025.100362_bib45","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1056\/NEJMoa2307079","article-title":"Efficacy and safety of an mRNA-based RSV PreF vaccine in older adults","volume":"389","author":"Wilson","year":"2023","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.jhlto.2025.100362_bib46","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1056\/NEJMoa2110275","article-title":"Nirsevimab for prevention of RSV in healthy late-preterm and term infants","volume":"386","author":"Hammitt","year":"2022","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.jhlto.2025.100362_bib47","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2024-066508","article-title":"Safety and pharmacokinetics of nirsevimab in immunocompromised children","volume":"154","author":"Domachowske","year":"2024","journal-title":"Pediatrics"},{"key":"10.1016\/j.jhlto.2025.100362_bib48","first-page":"72","article-title":"Use of nirsevimab for the prevention of respiratory syncytial virus disease among infants and young children: recommendations of the Advisory Committee on Immunization Practices\u2014United States, 2023","author":"Jones","year":"2023","journal-title":"MMWR Morbid Mortal Weekly Rep"},{"issue":"6","key":"10.1016\/j.jhlto.2025.100362_bib49","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1097\/TP.0000000000002985","article-title":"Oral and inhaled ribavirin treatment for respiratory syncytial virus infection in lung transplant recipients","volume":"104","author":"Permpalung","year":"2020","journal-title":"Transplantation"},{"issue":"7","key":"10.1016\/j.jhlto.2025.100362_bib50","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1592\/phco.24.9.932.36090","article-title":"Treatment of respiratory syncytial virus pneumonia in a lung transplant recipient: case report and review of the literature","volume":"24","author":"Flynn","year":"2004","journal-title":"Pharmacotherapy"},{"issue":"12","key":"10.1016\/j.jhlto.2025.100362_bib51","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.1111\/ajt.16073","article-title":"Evaluation of 10 years of parainfluenza virus, human metapneumovirus, and respiratory syncytial virus infections in lung transplant recipients","volume":"20","author":"de Zwart","year":"2020","journal-title":"Am J Transplant"},{"issue":"7","key":"10.1016\/j.jhlto.2025.100362_bib52","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.healun.2015.01.009","article-title":"Oral ribavirin for respiratory syncytial virus infection after lung transplantation: efficacy and cost-efficiency","volume":"34","author":"Burrows","year":"2015","journal-title":"J Heart Lung Transplant"},{"issue":"2","key":"10.1016\/j.jhlto.2025.100362_bib53","doi-asserted-by":"crossref","DOI":"10.1111\/tid.12844","article-title":"Comparative effectiveness of aerosolized versus oral ribavirin for the treatment of respiratory syncytial virus infections: A single-center retrospective cohort study and review of the literature","volume":"20","author":"Trang","year":"2018","journal-title":"Transpl Infect Dis"},{"issue":"1","key":"10.1016\/j.jhlto.2025.100362_bib54","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.healun.2008.10.008","article-title":"Efficacy of oral ribavirin in lung transplant patients with respiratory syncytial virus lower respiratory tract infection","volume":"28","author":"Pelaez","year":"2009","journal-title":"J Heart Lung Transplant"},{"issue":"1","key":"10.1016\/j.jhlto.2025.100362_bib55","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1399-3062.2009.00453.x","article-title":"A multi-drug regimen for respiratory syncytial virus and parainfluenza virus infections in adult lung and heart\u2013lung transplant recipients","volume":"12","author":"Liu","year":"2010","journal-title":"Transplant Infect Dis"},{"issue":"8","key":"10.1016\/j.jhlto.2025.100362_bib56","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.healun.2012.04.002","article-title":"Oral versus inhaled ribavirin therapy for respiratory syncytial virus infection after lung transplantation","volume":"31","author":"Li","year":"2012","journal-title":"J Heart Lung Transplant"},{"issue":"9","key":"10.1016\/j.jhlto.2025.100362_bib57","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.1007\/s12325-022-02256-5","article-title":"Ribavirin for treatment of subjects with respiratory syncytial virus-related infection: a systematic review and meta-analysis","volume":"39","author":"Tejada","year":"2022","journal-title":"Adv Ther"},{"issue":"7","key":"10.1016\/j.jhlto.2025.100362_bib58","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.healun.2023.01.013","article-title":"A randomized controlled trial of presatovir for respiratory syncytial virus after lung transplant","volume":"42","author":"Gottlieb","year":"2023","journal-title":"J Heart Lung Transplant"},{"issue":"9","key":"10.1016\/j.jhlto.2025.100362_bib59","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1093\/cid\/ciy294","article-title":"A 5-year prospective multicenter evaluation of influenza infection in transplant recipients","volume":"67","author":"Kumar","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.jhlto.2025.100362_bib60","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S1473-3099(10)70133-X","article-title":"Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study","volume":"10","author":"Kumar","year":"2010","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"10.1016\/j.jhlto.2025.100362_bib61","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/j.1600-6143.2010.03422.x","article-title":"The Impact of Pandemic Influenza A H1N1 2009 on Australian Lung Transplant Recipients","volume":"11","author":"Ng","year":"2011","journal-title":"Am J Transplant"},{"issue":"4","key":"10.1016\/j.jhlto.2025.100362_bib62","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00042-19","article-title":"Community-acquired respiratory viruses in transplant patients: diversity, impact, unmet clinical needs","volume":"32","author":"Ison","year":"2019","journal-title":"Clin Microbiol Rev"},{"issue":"5","key":"10.1016\/j.jhlto.2025.100362_bib63","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S1053-2498(01)00405-3","article-title":"Respiratory viruses and chronic rejection in lung transplant recipients","volume":"21","author":"Billings","year":"2002","journal-title":"J Heart Lung Transplant"},{"issue":"3","key":"10.1016\/j.jhlto.2025.100362_bib64","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1034\/j.1399-3062.2001.003003138.x","article-title":"Community respiratory virus infections following lung transplantation","volume":"3","author":"Billings","year":"2001","journal-title":"Transplant Infect Dis: Review article"},{"key":"10.1016\/j.jhlto.2025.100362_bib65","series-title":"Seminars in Thoracic and Cardiovascular Surgery","article-title":"Community acquired respiratory viral infections after lung transplantation: clinical features and long-term consequences","year":"2004"},{"issue":"2","key":"10.1016\/j.jhlto.2025.100362_bib66","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1164\/rccm.200310-1359OC","article-title":"Respiratory viral infections are a distinct risk for bronchiolitis obliterans syndrome and death","volume":"170","author":"Khalifah","year":"2004","journal-title":"Am J Respir Crit Care Medicine"},{"issue":"8","key":"10.1016\/j.jhlto.2025.100362_bib67","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1111\/j.1600-6143.2005.00971.x","article-title":"Clinical impact of community-acquired respiratory viruses on bronchiolitis obliterans after lung transplant","volume":"5","author":"Kumar","year":"2005","journal-title":"Am J Transplant"},{"issue":"7","key":"10.1016\/j.jhlto.2025.100362_bib68","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1097\/00007890-200204150-00010","article-title":"Influenza and parainfluenza respiratory viral infection requiring admission in adult lung transplant recipients","volume":"73","author":"Vilchez","year":"2002","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.jhlto.2025.100362_bib69","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1034\/j.1600-6143.2002.20315.x","article-title":"Influenza virus infection in adult solid organ transplant recipients","volume":"2","author":"Vilchez","year":"2002","journal-title":"Am J Transplant"},{"issue":"4","key":"10.1016\/j.jhlto.2025.100362_bib70","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1378\/chest.119.4.1277","article-title":"Influenza pneumonia in lung transplant recipients: clinical features and association with bronchiolitis obliterans syndrome","volume":"119","author":"Garantziotis","year":"2001","journal-title":"Chest"},{"issue":"7","key":"10.1016\/j.jhlto.2025.100362_bib71","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1093\/cid\/ciy1047","article-title":"Community-acquired respiratory viruses are a risk factor for chronic lung allograft dysfunction","volume":"69","author":"Peghin","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.jhlto.2025.100362_bib72","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.healun.2011.01.707","article-title":"Pandemic 2009 H1N1 influenza virus vaccination in lung transplant recipients: coverage, safety and clinical effectiveness in the Zurich cohort","volume":"30","author":"Schuurmans","year":"2011","journal-title":"J Heart Lung Transplant"},{"issue":"9","key":"10.1016\/j.jhlto.2025.100362_bib73","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13563","article-title":"Practice TAICo. vaccination of solid organ transplant candidates and recipients: guidelines from the American society of transplantation infectious diseases community of practice","volume":"33","author":"Danziger-Isakov","year":"2019","journal-title":"Clinical Transplant"},{"issue":"11","key":"10.1016\/j.jhlto.2025.100362_bib74","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1111\/j.1600-6143.2007.01982.x","article-title":"Immunogenicity and safety of an intradermal boosting strategy for vaccination against influenza in lung transplant recipients","volume":"7","author":"Manuel","year":"2007","journal-title":"Am J Transplant"},{"issue":"6","key":"10.1016\/j.jhlto.2025.100362_bib75","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1183\/09031936.01.00215201","article-title":"The humoral immune response to influenza vaccination in lung transplant patients","volume":"18","author":"Mazzone","year":"2001","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.jhlto.2025.100362_bib76","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1111\/ajt.16295","article-title":"Alternative strategies of posttransplant influenza vaccination in adult solid organ transplant recipients","volume":"21","author":"Haddadin","year":"2021","journal-title":"Am J Transplant"},{"issue":"11","key":"10.1016\/j.jhlto.2025.100362_bib77","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1093\/cid\/cix1082","article-title":"A double-blind, randomized trial of high-dose vs standard-dose influenza vaccine in adult solid-organ transplant recipients","volume":"66","author":"Natori","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.jhlto.2025.100362_bib78","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/petr.12419","article-title":"Randomized, double-blind comparison of standard-dose vs. high-dose trivalent inactivated influenza vaccine in pediatric solid organ transplant patients","volume":"19","author":"GiaQuinta","year":"2015","journal-title":"Pediatr Transplant"},{"issue":"7","key":"10.1016\/j.jhlto.2025.100362_bib79","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/cid\/ciw855","article-title":"Two doses of inactivated influenza vaccine improve immune response in solid organ transplant recipients: results of TRANSGRIPE 1\u20132, a randomized controlled clinical trial","volume":"64","author":"Cordero","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.jhlto.2025.100362_bib80","doi-asserted-by":"crossref","first-page":"955","DOI":"10.3851\/IMP2192","article-title":"Efficacy and safety of oral oseltamivir for influenza prophylaxis in transplant recipients","volume":"17","author":"Ison","year":"2012","journal-title":"Antiviral Ther"},{"issue":"1","key":"10.1016\/j.jhlto.2025.100362_bib81","first-page":"1","article-title":"Antiviral agents for the treatment and chemoprophylaxis of influenza\u2014recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"60","author":"Fiore","year":"2011","journal-title":"MMWR Recomm Rep"},{"issue":"3","key":"10.1016\/j.jhlto.2025.100362_bib82","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.healun.2007.11.575","article-title":"Outcome of influenza infection managed with oseltamivir in lung transplant recipients","volume":"27","author":"Ison","year":"2008","journal-title":"J Heart Lung Transplant"},{"issue":"7","key":"10.1016\/j.jhlto.2025.100362_bib83","doi-asserted-by":"crossref","first-page":"500","DOI":"10.7326\/0003-4819-156-7-201204030-00403","article-title":"Accuracy of rapid influenza diagnostic tests: a meta-analysis","volume":"156","author":"Chartrand","year":"2012","journal-title":"Ann Intern Med"},{"issue":"10","key":"10.1016\/j.jhlto.2025.100362_bib84","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1056\/NEJMoa1716197","article-title":"Baloxavir marboxil for uncomplicated influenza in adults and adolescents","volume":"379","author":"Hayden","year":"2018","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.jhlto.2025.100362_bib85","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13336","article-title":"Baloxavir for the treatment of Influenza in allogeneic hematopoietic stem cell transplant recipients previously treated with oseltamivir","volume":"22","author":"Salvatore","year":"2020","journal-title":"Transplant Infect Dis"},{"issue":"2","key":"10.1016\/j.jhlto.2025.100362_bib86","doi-asserted-by":"crossref","DOI":"10.1111\/tid.14249","article-title":"Clinical outcomes of baloxavir versus oseltamivir in immunocompromised patients","volume":"26","author":"Ringer","year":"2024","journal-title":"Transplant Infect Dis"},{"issue":"7","key":"10.1016\/j.jhlto.2025.100362_bib87","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofac206","article-title":"Safety and immunogenicity of an mRNA-based human metapneumovirus and parainfluenza virus type 3 combined vaccine in healthy adults","volume":"9","author":"August","year":"2022","journal-title":"Open Forum Infect Dis"},{"issue":"4","key":"10.1016\/j.jhlto.2025.100362_bib88","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0022-5223(98)70168-0","article-title":"Adenovirus infection in the lung results in graft failure after lung transplantation","volume":"116","author":"Bridges","year":"1998","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"9","key":"10.1016\/j.jhlto.2025.100362_bib89","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13527","article-title":"Practice AIDCo. Adenovirus in solid organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice","volume":"33","author":"Florescu","year":"2019","journal-title":"Clinical Transplant"},{"issue":"10","key":"10.1016\/j.jhlto.2025.100362_bib90","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/0046-8177(95)90268-6","article-title":"Adenovirus pneumonia in lung transplant recipients","volume":"26","author":"Ohori","year":"1995","journal-title":"Hum Pathol"},{"issue":"12","key":"10.1016\/j.jhlto.2025.100362_bib91","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/j.healun.2006.09.015","article-title":"Assessment of adenovirus infection in adult lung transplant recipients using molecular surveillance","volume":"25","author":"Humar","year":"2006","journal-title":"J Heart Lung Transplant"},{"issue":"2-3","key":"10.1016\/j.jhlto.2025.100362_bib92","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.antiviral.2006.04.007","article-title":"Antiviral therapy for adenovirus infections","volume":"71","author":"Lenaerts","year":"2006","journal-title":"Antiviral Res"},{"issue":"9","key":"10.1016\/j.jhlto.2025.100362_bib93","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.healun.2007.06.009","article-title":"Treatment of adenovirus pneumonia with cidofovir in pediatric lung transplant recipients","volume":"26","author":"Doan","year":"2007","journal-title":"J Heart Lung Transplant"},{"issue":"12","key":"10.1016\/j.jhlto.2025.100362_bib94","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1002\/phar.2194","article-title":"Adjunctive use of cidofovir and intravenous immunoglobulin to treat invasive adenoviral disease in solid organ transplant recipients","volume":"38","author":"Permpalung","year":"2018","journal-title":"Pharmacotherapy"},{"issue":"7","key":"10.1016\/j.jhlto.2025.100362_bib95","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms11071750","article-title":"Adenovirus infection in hematopoietic and solid organ paediatric transplant recipients: treatment, outcomes, and use of cidofovir","volume":"11","author":"Grasa","year":"2023","journal-title":"Microorganisms"},{"issue":"11","key":"10.1016\/j.jhlto.2025.100362_bib96","first-page":"987","article-title":"Efficacy of brincidofovir in pediatric stem cell transplant recipients with adenovirus infections","volume":"10","author":"Ehlert","year":"2021","journal-title":"J Pediatr Infect Dis Soc"},{"issue":"7","key":"10.1016\/j.jhlto.2025.100362_bib97","doi-asserted-by":"crossref","first-page":"e467","DOI":"10.1097\/MPH.0000000000001480","article-title":"Brincidofovir as a salvage therapy in controlling adenoviremia in pediatric recipients of hematopoietic stem cell transplant","volume":"41","author":"Meena","year":"2019","journal-title":"J Pediatr Hematol\/Oncol"},{"issue":"7","key":"10.1016\/j.jhlto.2025.100362_bib98","doi-asserted-by":"crossref","DOI":"10.1111\/petr.13769","article-title":"Brincidofovir for the treatment of human adenovirus infection in pediatric solid organ transplant recipients: A case series","volume":"24","author":"Londeree","year":"2020","journal-title":"Pediatr Transplant"},{"issue":"11","key":"10.1016\/j.jhlto.2025.100362_bib99","doi-asserted-by":"crossref","first-page":"e4090","DOI":"10.1093\/cid\/ciaa1097","article-title":"Coronavirus Disease 2019 in solid organ transplant: a multicenter cohort study","volume":"73","author":"Kates","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.jhlto.2025.100362_bib100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0257807","article-title":"COVID-19 in lung transplant recipients-Risk prediction and outcomes","volume":"16","author":"Kamp","year":"2021","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.jhlto.2025.100362_bib101","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.healun.2023.10.010","article-title":"Evolving impact of the COVID-19 pandemic on lung transplant recipients: a single-center experience","volume":"43","author":"Sindu","year":"2024","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.jhlto.2025.100362_bib102","doi-asserted-by":"crossref","DOI":"10.3389\/ti.2024.12061","article-title":"COVID-19 outcomes in lung transplant recipients following pre-exposure prophylaxis with tixagevimab-cilgavimab during the omicron BA.5 Surge: a single center analysis","volume":"37","author":"Demolder","year":"2024","journal-title":"Transpl Int"},{"issue":"3","key":"10.1016\/j.jhlto.2025.100362_bib103","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s15010-022-01914-8","article-title":"Outcome of lung transplant recipients infected with SARS-CoV-2\/Omicron\/B. 1.1. 529: a Nationwide German study","volume":"51","author":"Kneidinger","year":"2023","journal-title":"Infection"},{"issue":"1","key":"10.1016\/j.jhlto.2025.100362_bib104","doi-asserted-by":"crossref","DOI":"10.1111\/tid.14007","article-title":"Outcomes of SARS-CoV-2 infection among lung transplant recipients: A single center retrospective study","volume":"25","author":"Casutt","year":"2023","journal-title":"Transpl Infect Dis"},{"issue":"8","key":"10.1016\/j.jhlto.2025.100362_bib105","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.29736","article-title":"Incident COVID-19 and hospitalizations by variant era among vaccinated solid organ transplant recipients","volume":"6","author":"Chiang","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.jhlto.2025.100362_bib106","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/cid\/ciad477","article-title":"Immunogenicity of high-dose versus mf59-adjuvanted versus standard influenza vaccine in solid organ transplant recipients: the Swiss\/Spanish Trial in Solid Organ Transplantation on Prevention of Influenza (STOP-FLU Trial)","volume":"78","author":"Mombelli","year":"2024","journal-title":"Clin Infect Dis"}],"container-title":["JHLT Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950133425001570?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950133425001570?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T09:50:25Z","timestamp":1763027425000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950133425001570"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":106,"alternative-id":["S2950133425001570"],"URL":"https:\/\/doi.org\/10.1016\/j.jhlto.2025.100362","relation":{},"ISSN":["2950-1334"],"issn-type":[{"value":"2950-1334","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Respiratory viral infections in lung transplantation: Recent advances in epidemiology, clinical impact, and therapeutic approaches","name":"articletitle","label":"Article Title"},{"value":"JHLT Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhlto.2025.100362","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of International Society for Heart and Lung Transplantation.","name":"copyright","label":"Copyright"}],"article-number":"100362"}}